会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 25. 发明申请
    • CARDIAC ANALYSIS SYSTEM FOR COMPARING CLINICAL AND INDUCED VENTRICULAR TACHYCARDIA EVENTS
    • 用于比较临床和诱发的心室TACHYCARDIA事件的心脏分析系统
    • US20110282226A1
    • 2011-11-17
    • US12820879
    • 2010-06-22
    • Michael E. BenserGene A. BornzinEuljoon ParkKyungmoo RyuMichael Hardage
    • Michael E. BenserGene A. BornzinEuljoon ParkKyungmoo RyuMichael Hardage
    • A61B5/04
    • A61B5/0422A61B5/0031A61B5/0464A61B18/1492A61N1/3621
    • A cardiac analysis system is provided that includes an implantable medical device (IMD), at least one sensor, and an external device. The IMD has electrodes positioned proximate to a heart that sense first cardiac signals of the heart and associated with a clinical ventricular tachycardia (VT) event and second cardiac signals associated with an induced VT event. The sensor measures first and second cardiac parameters of the heart associated with the clinical and induced VT events, respectively. The external device is configured to receive the first and second cardiac signals associated with the clinical and the induced VT events and the first and second cardiac parameters associated with the clinical and the induced VT events. The external device compares the first and second cardiac signals and compares the first and second cardiac parameters to determine if the clinical and induced VT events are a common type of VT event.
    • 提供了包括可植入医疗装置(IMD),至少一个传感器和外部装置的心脏分析系统。 IMD具有位于心脏附近的电极,其感测心脏的第一心脏信号并与临床心室性心动过速(VT)事件和与诱导的VT事件相关联的第二心脏信号相关联。 该传感器分别测量与临床和诱导VT事件相关的心脏的第一和第二心脏参数。 外部设备被配置为接收与临床和诱导的VT事件相关联的第一和第二心脏信号以及与临床和诱导的VT事件相关联的第一和第二心脏参数。 外部设备比较第一和第二心脏信号,并比较第一和第二心脏参数以确定临床和诱导的VT事件是否是常见类型的VT事件。
    • 26. 发明授权
    • Cardiac analysis system for comparing clinical and induced ventricular tachycardia events
    • 用于比较临床和诱导性室性心动过速事件的心脏分析系统
    • US08634902B2
    • 2014-01-21
    • US12820879
    • 2010-06-22
    • Michael E. BenserGene A. BornzinEuljoon ParkKyungmoo RyuMichael Hardage
    • Michael E. BenserGene A. BornzinEuljoon ParkKyungmoo RyuMichael Hardage
    • A61B5/04
    • A61B5/0422A61B5/0031A61B5/0464A61B18/1492A61N1/3621
    • A cardiac analysis system is provided that includes an implantable medical device (IMD), at least one sensor, and an external device. The IMD has electrodes positioned proximate to a heart that sense first cardiac signals of the heart and associated with a clinical ventricular tachycardia (VT) event and second cardiac signals associated with an induced VT event. The sensor measures first and second cardiac parameters of the heart associated with the clinical and induced VT events, respectively. The external device is configured to receive the first and second cardiac signals associated with the clinical and the induced VT events and the first and second cardiac parameters associated with the clinical and the induced VT events. The external device compares the first and second cardiac signals and compares the first and second cardiac parameters to determine if the clinical and induced VT events are a common type of VT event.
    • 提供了包括可植入医疗装置(IMD),至少一个传感器和外部装置的心脏分析系统。 IMD具有位于心脏附近的电极,其感测心脏的第一心脏信号并与临床心室性心动过速(VT)事件和与诱导的VT事件相关联的第二心脏信号相关联。 该传感器分别测量与临床和诱导VT事件相关的心脏的第一和第二心脏参数。 外部设备被配置为接收与临床和诱导的VT事件相关联的第一和第二心脏信号以及与临床和诱导的VT事件相关联的第一和第二心脏参数。 外部设备比较第一和第二心脏信号,并比较第一和第二心脏参数以确定临床和诱导的VT事件是否是常见类型的VT事件。
    • 28. 发明授权
    • System and method for controlling ventricular pacing during AF based on underlying ventricular rates using an implantable medical device
    • 使用植入式医疗设备,根据潜在的心室率控制房颤期间心室起搏的系统和方法
    • US08340765B2
    • 2012-12-25
    • US12410386
    • 2009-03-24
    • Peter BoileauMichael E. Benser
    • Peter BoileauMichael E. Benser
    • A61N1/36
    • A61N1/3622A61N1/3702
    • Techniques are provided for controlling ventricular pacing during an episode of atrial fibrillation (AF) for use by a pacemaker, implantable cardioverter-defibrillator (ICD) or other implantable medical device. In one example, upon detection of AF, the underlying intrinsic ventricular rate of the patient is determined prior to delivering any ventricular pacing. Then, a ventricular pacing procedure—such as dynamic ventricular overdrive (DVO) pacing—is activated to reduce ventricular rate variability to mitigate the adverse effects of AF. The ventricular pacing procedure employed during AF is controlled based on a maximum ventricular rate set relative to the underlying intrinsic ventricular rate so as to keep an overall ventricular rate below the maximum rate.
    • 提供技术用于在心房颤动(AF)发作期间控制心室起搏,以供起搏器,可植入式心律转复除颤器(ICD)或其他可植入医疗装置使用。 在一个实例中,在检测到AF后,在递送任何心室起搏之前确定患者的潜在内在心室率。 然后,启动心室起搏手术,例如动态心室超速(DVO)起搏 - 以减少心室率变异性,以减轻AF的不良反应。 在AF期间使用的心室起搏过程基于相对于潜在的内部心室率设定的最大心室率进行控制,以保持总体心率低于最大速率。
    • 30. 发明授权
    • Bachmann's bundle electrode for atrial defibrillation
    • 巴赫曼的束电极用于心房除颤
    • US06804553B2
    • 2004-10-12
    • US09978513
    • 2001-10-15
    • Xiangsheng ZhengMichael E. BenserRaymond E. IdekerGregory P. WalcottSteven D. Girouard
    • Xiangsheng ZhengMichael E. BenserRaymond E. IdekerGregory P. WalcottSteven D. Girouard
    • A61N139
    • A61N1/0563A61N1/395A61N1/3956A61N2001/0585
    • An implantable system for the defibrillation of the atria of a patient's heart comprises (a) a first catheter configured for insertion into the right atrium of the heart; a first atrial defibrillation electrode carried by the first catheter and positioned to stimulate Bachmann's bundle, or positioned at the atrial septum of the heart (i.e., an atrial septum electrode); (b) a second atrial defibrillation electrode which together with the first atrial defibrillation electrode provides a pair of atrial defibrillation electrodes that are configured for orientation in or about the patient's heart to effect atrial defibrillation, and (c) a pulse generator operatively associated with the pair of atrial defibrillation electrodes for delivering a first atrial defibrillation pulse to the heart of the patient. The second electrode may be configured for positioning through the coronary sinus ostium and in the coronary sinus or a vein on the surface of the left ventricle, such as the great vein. An additional electrode configured for positioning in the superior vena cava, right atrium (including the right atrial appendage, or the right ventricle may also be included, and the pulse generator may be configured or programmed for concurrently delivering a first defibrillation pulse through the additional electrode and the atrial septum electrode, and a second defibrillation pulse through the atrial septum electrode and the second electrode. Electrode assemblies and methods useful for carrying out the invention are also disclosed.
    • 用于对患者心脏的心房进行除颤的可植入系统包括(a)构造成用于插入心脏右心房的第一导管; 由第一导管携带并定位成刺激巴赫曼氏束或定位在心脏的心房隔膜(即心房隔膜电极)处的第一心房除颤电极; (b)第二心房除颤电极,与第一心房除颤电极一起提供一对心房除颤电极,其构造成用于在患者心脏内或周围定向以实现心房除颤,以及(c)与 一对心房除颤电极,用于将第一心房除颤脉冲输送到患者的心脏。 第二电极可以被配置用于定位穿过冠状窦口和冠状窦或左心室表面的静脉,例如大静脉。 还可以包括配置用于定位在上腔静脉,右心房(包括右心耳或右心室)中的附加电极,并且脉冲发生器可以被配置或编程用于同时递送通过附加电极的第一除颤脉冲 以及通过心房隔膜电极和第二电极的第二除颤脉冲,还公开了用于实施本发明的电极组件和方法。